
FDA-approved · Cash-pay · Ships to your door
Ozempic®
FDA-approved semaglutide pen, off-label for weight loss. Activates GLP-1 to lower blood sugar and appetite.
- FDA-approved for type 2 diabetes
- Weekly injection; one pen lasts a month
- Same price at every dose, cancel anytime
- Cash-pay only; not billed to insurance
Ozempic® is the FDA-approved semaglutide product from Novo Nordisk A/S, indicated for type 2 diabetes mellitus to improve glycemic control alongside diet and exercise. It is sometimes prescribed off-label for weight management at the discretion of a licensed clinician when clinically indicated.
The easiest way to find out is to start. Our US-licensed provider partners review a short online intake — usually just a few minutes — and determine what's right for you on an individual basis, based on your health history and goals. There's no cost to find out and no obligation.
Yes. Shipping is always free, and every order arrives in plain, unmarked packaging from a US-licensed pharmacy — no one needs to know what's inside. Most orders arrive within about a week of approval.
Yes. Pallas is a cash-pay medical service, and we provide an itemized receipt for your visit and prescription that you can submit to your FSA or HSA. Most plans treat prescription medications and telehealth visits as eligible expenses — your plan administrator can confirm what applies to you.
About
What is Ozempic®?
Ozempic® is the FDA-approved semaglutide product from Novo Nordisk A/S, indicated for type 2 diabetes mellitus to improve glycemic control alongside diet and exercise. It is sometimes prescribed off-label for weight management at the discretion of a licensed clinician when clinically indicated.
Pallas dispenses Ozempic® through US-licensed pharmacies on a cash-pay basis. Insurance routing is not currently supported. Eligibility is determined by a licensed clinician based on your intake and clinical history.
Pivotal trial · SUSTAIN program
In the SUSTAIN clinical program, semaglutide demonstrated significant HbA1c reductions vs. comparators across a range of T2D populations.
Source: Novo Nordisk SUSTAIN trial program. Outcome reflects the cited trial of the FDA-approved product and the conditions studied. Individual results may differ.
Dosing
Dosing & schedule
Ozempic® follows a dose-titration schedule. Your clinician determines the right starting dose and pace of escalation based on your indication and tolerability.
- Weeks 1–40.25 mg once weekly — starting dose (non-therapeutic, for tolerability)
- Weeks 5–80.5 mg once weekly
- Weeks 9+Maintenance dose between 1.0 mg and 2.0 mg weekly, per clinician judgment
Common questions
The easiest way to find out is to start. Our US-licensed provider partners review a short online intake — usually just a few minutes — and determine what's right for you on an individual basis, based on your health history and goals. There's no cost to find out and no obligation.
Yes. Shipping is always free, and every order arrives in plain, unmarked packaging from a US-licensed pharmacy — no one needs to know what's inside. Most orders arrive within about a week of approval.
Yes. Pallas is a cash-pay medical service, and we provide an itemized receipt for your visit and prescription that you can submit to your FSA or HSA. Most plans treat prescription medications and telehealth visits as eligible expenses — your plan administrator can confirm what applies to you.
We'll make it right. Pallas includes unlimited customer support — if anything's off with your shipment, or you simply have a question about your treatment, our support team and your care team are a message away, as often as you need, at no extra cost.
Pallas is cash-pay and doesn't bill insurance directly — that keeps your pricing simple and predictable. But because you receive the genuine, FDA-approved product with an itemized receipt, some patients choose to submit a claim to their insurer afterward for possible out-of-network reimbursement. Whether it's reimbursed is up to your individual plan.
Ozempic® is the brand name for the FDA-approved semaglutide injection manufactured by Novo Nordisk for type 2 diabetes. It's delivered as a once-weekly subcutaneous injection via a multi-dose pen.
Ozempic® is FDA-approved for type 2 diabetes, and a US-licensed clinician may prescribe it off-label for weight management when it's clinically appropriate for you. If weight is your main goal, your provider can also walk you through Wegovy® — the semaglutide product from the same manufacturer that's FDA-approved specifically for chronic weight management.
Ozempic® is $499 for your first month, then $649 every 4 weeks, charged only once a clinician prescribes, then renewing every 4 weeks until you cancel, with no insurance routing. Other terms are quarterly ($1,887 every 12 weeks, $629/mo average). The price is the same at every dose, and each charge covers a supply shipped directly from a US-licensed pharmacy.
Yes — no contracts and no lock-in. You can pause or cancel your plan anytime, right from your patient portal.
Ozempic®
$499 first month
- Cancel anytime
- Free expedited shipping
- FSA & HSA eligible
- Care-team messaging included
